A Phase 2, Multicenter Study To Assess The Efficacy And Safety Of Autologous Tumor-Infiltrating Lymphocytes (Ln-144) For The Treatment Of Patients With Metastatic Melanoma.

JOURNAL OF CLINICAL ONCOLOGY(2018)

引用 6|浏览43
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要